ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gynecological Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1567305
Temporal Trends of Cervical Cancer Demographics: A CDC WONDER Database Study
Provisionally accepted
Grace Folino1*
Isabella Zent1Lillian Eason1
Vikram Murugan1
Taylor Billion1
Ali Bin Abdul Jabbar2Mohsin Mirza2Abubakar Tauseef2- 1School of Medicine, Creighton University, Omaha, United States
- 2CHI Health Creighton University Medical Center Bergan Mercy, Omaha, Nebraska, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Despite advancements in cervical cancer screening and HPV vaccines, demographic disparities perpetuate the burden of cervical cancer. The aim of this study is to utilize the most up-to-date CDC WONDER data of cervical cancer mortality to provide a comprehensive temporal analysis of demographic variables and account for patients missed in other database studies. In doing so, temporal trends found in this study may be used to guide future efforts and studies to understand nuanced barriers to cervical cancer screening and prevention.With CDC WONDER Data, cervical cancer-related mortality was assessed in the U.S. from 1999 to 2023. Using age-adjusted mortality rates (AAMR), temporal trends were analyzed using the Joinpoint Regression Program for women 25 years and older across race, census regions, urban/rural residence, and states. Annual percentage change (APC) and average annual percentage change (AAPC) were calculated with 95% confidence intervals.Cervical cancer-related mortality declined over the study period with an AAPC of -1.043*. Between 2015 and 2023, there was a concerning positive change in AAMR [APC of 0.1272 (95% CI -0.3393 to 1.7502)], though not statistically significant. Black or African American patients experienced the highest AAMR across races but maintained a decrease in mortality rate over the study period [AAPC of -2.679* (95% CI -2.931 to -2.356)]. Region and race analysis demonstrated Black or African American patients in the Northeast held the largest decline in AAMR [AAPC of -3.218* (95% CI -3.708 to -2.390)], while Hispanic or Latino and Black or African American patients in the South closely followed [AAPC of -2.677* (95% CI -3.644 to -1.654) and -2.656* (95% CI -2.9389 to -2.350), respectively]. Rural areas (NonCore and Micropolitan) and the Southern region displayed a concerning positive trend after 2009 and 2010, though not statistically significant [APC values of 0.7717 (95% CI -0.3281 to 4.8878), 0.9865 (95% CI -0.2521 to 4.8871), and 0.2865 (95% CI -0.0611 to 0.7723), respectively].These findings underscore the need for targeted interventions with consideration of regional and racial temporal disparities in cervical cancer-related mortality.
Keywords: CDC WONDER, cervical cancer, HPV, Demographics, Health Disparities
Received: 27 Jan 2025; Accepted: 19 Jun 2025.
Copyright: © 2025 Folino, Zent, Eason, Murugan, Billion, Abdul Jabbar, Mirza and Tauseef. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Grace Folino, School of Medicine, Creighton University, Omaha, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.